Rheumatoid Arthritis Market and Epidemiology Forecast 2024-2034 Featuring Analysis of ATI-450 (Aclaris Therapeutics) and Olumiant/Baricitinib (Eli Lilly/Incyte)
June 25, 2024 12:36 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
US Rheumatoid Arthritis Market and Competitive Landscape Report 2021-2026: Pipeline Products, Epidemiology, Market Valuations and Forecasts, Drugs Sales
May 31, 2021 07:38 ET
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "US Rheumatoid Arthritis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Rheumatoid Arthritis...
$81 Billion Worldwide Musculoskeletal Disorders Drugs Industry to 2030 - Featuring Pfizer, Abbott Laboratories and Daiichi Sankyo Among Others
May 10, 2021 05:43 ET
|
Research and Markets
Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Musculoskeletal Disorders Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's...